Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection

来源 :肝癌研究(英文版) | 被引量 : 0次 | 上传用户:djgohx
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Aim: Robotic liver resection (RLR) is a new platform for minimally invasive hepatobiliary surgery. Minimally invasive surgery can confer benefits to patients with hepatocellular carcinoma (HCC), which is mostly associated with underlying chronic liver disease. Despite the inherent functional merits of robotics for surgical techniques, the clinical advantages of hepatectomy are not well defined. Therefore, we reviewed the short-term and long-term surgical results of 57 HCC cases in 46 patients who underwent RLR at our institution. Methods: We evaluated the feasibility and safety of robotic anatomic liver resection for HCC by comparing the results of the anatomic resection (AR) group (n = 23) and non-anatomic resection (NAR) group (n = 34). Results: Overall (n = 57), the liver-specific console time was 487 min, blood loss was 194 g, and there was one open conversion (2%). Postoperative data showed acceptable hepatic functional recovery, with a major complication rate of 11% and no 90-day mortality. Compared to NAR, AR was associated with longer operative and console times, more blood loss, and worse postoperative liver function, thus reflecting the greater extent and complexity of hepatectomies for more advanced-stage tumors than NAR. Nonetheless, major complication rate, mortality rate, length of hospital stay, and R0 resection rate were comparable between groups. Long-term results were comparable to those of previously reported hepatectomies for HCC and were similar between groups. Conclusion: RLR including AR may be a safe and feasible form of hepatectomy for select patients with HCC.
其他文献
目的探讨原位肝移植供肝获取过程中发生撕裂伤的处理方式。方法对2018年2月至2021年1月清华大学附属北京清华长庚医院297例原位肝移植手术中供肝撕裂伤的情况进行回顾性分析
Chronic infection of the liver by the hepatitis B virus (HBV) is associated with increased risk for developing hepatocellular carcinoma (HCC). A multitude of st
Hepatocellular carcinoma (HCC) is the fifth most widespread cancer responsible for one fourth of cancer-related deaths globally. Persistent infection with hepat
Mutations involving CTNNB1, the gene encoding beta-catenin, and other molecular alterations that affect the Wnt/beta-catenin signaling pathway are exceptionally
Hepatocellular carcinoma (HCC) is the most common type of primary liver malignancy and the fourth leading cause of cancer-related deaths globally. HCC is often
目的探讨经皮肝胆管穿刺碎石术(PTCSL)术后胆漏并发症的诊治及预防。方法回顾性总结分析2016年1月至2019年12月湖南省人民医院肝胆外科完成的40例PTCSL的病例资料。结果PTCS
Risk prediction modelling for hepatocellular carcinoma (HCC) has been the focus of research in the last decade. The prediction models would help HCC risk strati
Laparoscopic liver resection (LLR) has expanded to include major liver resection and systematic resection as the techniques have advanced. Regardless of the onc
Background: The impact of sarcopenia on the outcome of patients with cirrhosis who undergo liver transplantation (LT) has been analysed in heterogeneous cohorts
Non-alcoholic fatty liver disease (NAFLD) is one of the most prominent causes of liver-related morbidity in the Western world. NAFLD is a chronic disease charac